Redhawk Wealth Advisors, Inc. Abbott Laboratories Transaction History

Redhawk Wealth Advisors, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$100.73 - $112.44 $21,153 - $23,612	210 Added 9.62%	2,394 $248,000
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $1,095 - $1,209	10 Added 0.46%	2,184 $248,000
Q4 2023 Jan 12, 2024	BUY	$90.19 - $110.4 $196,073 - $240,009	2,174 New	2,174 $239,000
Q2 2023 Jul 13, 2023	BUY	$100.78 - $112.29 $200,048 - $222,895	1,985 New	1,985 $216,000
Q1 2022 Apr 21, 2022	SELL	$114.02 - $139.04 $610,463 - $744,420	-5,354 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $173,526 - $212,472	1,502 Added 38.99%	5,354 $754,000
Q3 2021 Nov 02, 2021	SELL	$116.66 - $129.06 $619,697 - $685,566	-5,312 Reduced 57.97%	3,852 $455,000
Q2 2021 Aug 04, 2021	SELL	$105.79 - $124.53 $19,994 - $23,536	-189 Reduced 2.02%	9,164 $1.06 Million
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $16,543 - $19,490	-152 Reduced 1.6%	9,353 $1.12 Million
Q4 2020 Jan 26, 2021	SELL	$105.0 - $114.42 $45,045 - $49,086	-429 Reduced 4.32%	9,505 $1.04 Million
Q3 2020 Nov 03, 2020	SELL	$91.64 - $111.29 $4,856 - $5,898	-53 Reduced 0.53%	9,934 $1.08 Million
Q2 2020 Jul 14, 2020	BUY	$76.57 - $98.0 $170,521 - $218,246	2,227 Added 28.7%	9,987 $913,000
Q1 2020 Apr 14, 2020	BUY	$62.82 - $91.86 $233,627 - $341,627	3,719 Added 92.03%	7,760 $612,000
Q4 2019 Feb 25, 2020	BUY	$78.51 - $87.4 $75,369 - $83,904	960 Added 31.16%	4,041 $351,000
Q3 2019 Oct 04, 2019	BUY	$81.84 - $88.74 $219,822 - $238,355	2,686 Added 680.0%	3,081 $258,000
Q2 2019 Aug 09, 2019	BUY	$72.88 - $85.0 $28,787 - $33,575	395 New	395 $33,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Redhawk Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Redhawk Wealth Advisors, Inc. with notifications on news.